Get to know our clinical trials
Clinical trial of RO7428731 in participants with glioblastoma with epidermal growth factor receptor variant III mutation.
RO7428731 IS A DRUG THAT HELPS THE IMMUNE SYSTEM BECOME ACTIVE TO BETTER FIGHT THE BRAIN TUMOR. THE PURPOSE OF THIS STUDY IS TO TEST THE EFFECTS (GOOD OR BAD) OF RO7428731 USING DIFFERENT DOSES, WHAT HAPPENS TO RO7428731 ONCE IT IS IN THE BODY, AND WHAT EFFECT RO7428731 HAS ON THE BODY.
- Code EudraCT: 2021-001197-37
- Protocol number: BP42573
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.